Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 281,843 | reported | 05 Jan 2026 | tx 69+3,466,971−487,166 |
| SYNERGY PHARMACEUTICALS, INC. | 189,056 | reported | 28 Jun 2017 | tx 4+206,556 |
| BROADRIDGE FINANCIAL SOLUTIONS, INC. | 103,489.99 | reported | 01 Apr 2025 | tx 374+8,931,804.03−8,199,746.03 |
| PALISADE BIO, INC. | 100,000 | reported | 07 Nov 2017 | tx 8+247,871 |
| AUTOMATIC DATA PROCESSING INC | 0 | reported | 02 Apr 2007 | tx 53+419,189.19−808,642.58 |
| Madrona Ventures, Inc. | 0 | reported | 02 Mar 2023 | tx 14+20,300−20,300 |
| ADT Corp | 0 | reported | 02 May 2016 | tx 18+10,987−10,987 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jan 2026 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 42,105 | — | |
| 05 Jan 2026 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 10,577 | — | |
| 05 Jan 2026 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 42,105 | 0.00 USD | deriv |
| 29 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,334 | — | |
| 29 Dec 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 524 | — | |
| 29 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,334 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 20,006 | — | |
| 21 Nov 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 7,872 | — | |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 381,948 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 115,283 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 20,006 | 0.00 USD | deriv |
| 26 Aug 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50,000 | 2.24 USD | |
| 26 Aug 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 22,970 | 20.62 USD | |
| 26 Aug 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 50,000 | 0.00 USD | deriv |
| 30 May 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 70,000 | 24.86 USD | |
| 01 Apr 2025 | TAX_WITHHOLDING | BROADRIDGE FINANCIAL SOLUTIONS, INC. | 604 | 244.72 USD | |
| 14 Feb 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4,000 | — | |
| 14 Feb 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 1,574 | — | |
| 14 Feb 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 4,000 | 0.00 USD | deriv |
| 04 Feb 2025 | GRANT_AWARD | BROADRIDGE FINANCIAL SOLUTIONS, INC. | 4,241 | 0.00 USD | deriv |
| 02 Jan 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 10,600 | — | |
| 02 Jan 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 42,105 | — | |
| 02 Jan 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 42,105 | 0.00 USD | deriv |
| 27 Dec 2024 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 324 | — | |
| 27 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,333 | — |
2 purchases reported after at least 12 months of silence — most recent on 12 Sept 2019.